Acorah Software Products - Accounts Production 19.4.300 false true 30 November 2024 1 December 2023 true 1 December 2024 30 November 2025 30 November 2025 07924432 Mrs Divya Patel Mr Harshad Patel Mr Mitul Patel iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 07924432 2024-11-30 07924432 2025-11-30 07924432 2024-12-01 2025-11-30 07924432 frs-core:SharePremium 2025-11-30 07924432 frs-core:ShareCapital 2025-11-30 07924432 frs-core:RetainedEarningsAccumulatedLosses 2025-11-30 07924432 frs-bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 07924432 frs-bus:FullAccounts 2024-12-01 2025-11-30 07924432 frs-bus:SmallEntities 2024-12-01 2025-11-30 07924432 frs-bus:AuditExemptWithAccountantsReport 2024-12-01 2025-11-30 07924432 frs-bus:SmallCompaniesRegimeForAccounts 2024-12-01 2025-11-30 07924432 frs-bus:SmallCompaniesRegimeForDirectorsReport 2024-12-01 2025-11-30 07924432 frs-core:CostValuation 2024-11-30 07924432 frs-core:CostValuation 2025-11-30 07924432 frs-core:ProvisionsForImpairmentInvestments 2024-11-30 07924432 frs-core:ProvisionsForImpairmentInvestments 2025-11-30 07924432 frs-bus:Director1 2024-12-01 2025-11-30 07924432 frs-bus:Director2 2024-12-01 2025-11-30 07924432 frs-bus:Director3 2024-12-01 2025-11-30 07924432 frs-countries:EnglandWales 2024-12-01 2025-11-30 07924432 2023-11-30 07924432 2024-11-30 07924432 2023-12-01 2024-11-30 07924432 frs-core:SharePremium 2023-11-30 07924432 frs-core:SharePremium 2024-11-30 07924432 frs-core:ShareCapital 2023-11-30 07924432 frs-core:ShareCapital 2024-11-30 07924432 frs-core:RetainedEarningsAccumulatedLosses frs-core:PreviouslyStatedAmount 2023-11-30 07924432 frs-core:RetainedEarningsAccumulatedLosses 2024-11-30
Registered number: 07924432
Pharmaco (Suffolk) Limited
Directors' Report and
Unaudited Financial Statements
For The Year Ended 30 November 2025
Contents
Page
Company Information 1
Directors' Report 2
Accountant's Report 3
Profit and Loss Account 4
Balance Sheet 5
Statement of Changes in Equity 6
Notes to the Financial Statements 7—8
Page 1
Company Information
Directors Mrs Divya Patel
Mr Harshad Patel
Mr Mitul Patel
Company Number 07924432
Registered Office Hunts Pharmacy
205 Plumstead Road
Norwich
Norfolk
NR1 4AB
Business 205 Plumstead Road
Norwich
Norfolk
NR1 4AB
Accountants Saii AG
Chartered Certified Accountants
Suite37/38 Marshall House,
124 Middleton Road
Morden
Surrey
SM4 6RW
Page 1
Page 2
Directors' Report
The directors present their report and the financial statements for the year ended 30 November 2025.
Principal Activity
The company's principal activity during the year is that of a holding company.
Directors
The directors who held office during the year were as follows:
Mrs Divya Patel
Mr Harshad Patel
Mr Mitul Patel
Small Company Rules
This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.
On behalf of the board
Mr Mitul Patel
Director
21 July 2026
Page 2
Page 3
Accountant's Report
Report to the directors on the preparation of the unaudited statutory accounts of Pharmaco (Suffolk) Limited for the year ended 30 November 2025
To assist you to fulfil your duties under the Companies Act 2006, I have prepared for your approval the accounts of Pharmaco (Suffolk) Limited which comprise the Profit and Loss Account, the Balance Sheet and the related notes, from the company’s accounting records and from information and explanations you have given us.
As a practising member of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at http://www.accaglobal.com/en/member/professional-standards/rules-standards/acca-rulebook.html.
This report is made to the directors of Pharmaco (Suffolk) Limited , as a body, in accordance with the terms of our engagement letter dated 07 July 2020. Our work has been undertaken solely to prepare for your approval the accounts of Pharmaco (Suffolk) Limited and state those matters that we have agreed to state to the directors of Pharmaco (Suffolk) Limited , as a body, in this report in accordance with the Association of Chartered Certified Accountants as detailed at http://www.accaglobal.com/content/dam/ACCA_Global/Technical/fact/technical-factsheet-163.pdf. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Pharmaco (Suffolk) Limited and its directors as a body for our work or for this report.
It is your duty to ensure that Pharmaco (Suffolk) Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit or loss of Pharmaco (Suffolk) Limited . You consider that Pharmaco (Suffolk) Limited is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the accounts of Pharmaco (Suffolk) Limited . For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the financial statements.
Saii AG LLP
21 July 2026
Saii AG
Chartered Certified Accountants
Suite37/38 Marshall House,
124 Middleton Road
Morden
Surrey
SM4 6RW
Page 3
Page 4
Profit and Loss Account
2025 2024
Notes £ £
The notes on pages 7 to 8 form part of these financial statements.
Page 4
Page 5
Balance Sheet
2025 2024
Notes £ £ £ £
FIXED ASSETS
Investments 4 3,812,767 3,812,767
3,812,767 3,812,767
TOTAL ASSETS LESS CURRENT LIABILITIES 3,812,767 3,812,767
NET ASSETS 3,812,767 3,812,767
CAPITAL AND RESERVES
Called up share capital 2,332 2,332
Share premium account 1,330,668 1,330,668
Profit and Loss Account 2,479,767 2,479,767
SHAREHOLDERS' FUNDS 3,812,767 3,812,767
For the year ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Mitul Patel
Director
21 July 2026
The notes on pages 7 to 8 form part of these financial statements.
Page 5
Page 6
Statement of Changes in Equity
Share Capital Share Premium Profit and Loss Account Total
£ £ £ £
As at 1 December 2023 2,332 1,330,668 2,479,767 3,812,767
As at 30 November 2024 and 1 December 2024 2,332 1,330,668 2,479,767 3,812,767
As at 30 November 2025 2,332 1,330,668 2,479,767 3,812,767
Page 6
Page 7
Notes to the Financial Statements
1. General Information
Pharmaco (Suffolk) Limited is a private company, limited by shares, incorporated in England & Wales, registered number 07924432 . The registered office is Hunts Pharmacy, 205 Plumstead Road, Norwich, Norfolk, NR1 4AB.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Provisions
Provisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 3 (2024: 3)
3 3
4. Investments
Subsidiaries
£
Cost or Valuation
As at 1 December 2024 3,812,767
As at 30 November 2025 3,812,767
Provision
As at 1 December 2024 -
As at 30 November 2025 -
Net Book Value
As at 30 November 2025 3,812,767
As at 1 December 2024 3,812,767
Details of undertakings
Details of investments (including principal place of business of unincorporated entities) in which the company holds 20% or more of the nominal value of any class of share capital are as follows:
Undertaking                                                  Holding                           Proporation of voting rights &shares held
Subsidiary undertakings
Mid Suffolk Medical Supplies Limited            Ordinary shares              100%
Registered office
C/o Hunts Pharmacy, 205 Plumstead Road, Norwich, Norfolk, United Kingdom, NR1 4AB
The principal activity of Mid Suffolk Medical Supplies Limited is supply medicines and other goods as a pharmacy.
The profit for the financial period of Mid Suffolk Medical Supplies Limited was £309,467.09 and the aggregate amount of capital and reserves  at the end of the period was £5,299,973.73.
Page 7
Page 8
5. Related Party Transactions
Mr Harshad Patel, Mrs Divya Patel and Mr Mitul Patel are directors of the company.
At the end of the year amount owed by the company to the directors is £Nil (2024: £0.00).
During the year, the company has declared dividend of £Nil (2024: £0.00).
6. Summary of transactions with subsidiaries
Mid Suffolk Medical Supplies Limited
(100% subsidiary undertaking of Pharmaco (Suffolk) Limited )
During the the year company owed to Mid Suffolk Medical Supplies Limited was £0.00 (2024: £0.00).  The balance is interest free and repayble on demand.
Page 8